Sudarshan Ramanan

Medical Student | @JeffersonUniv @UofR | Views are my own.

[Sudarshan Ramanan @sramanan03]

Excited to share our latest paper in the Journal of Clinical Oncology. Grateful to my co-authors
@EChrisDee, @imrtlee, @seanmmcbride, @xrtGenomics, @george_ashji, Eric Sherman, Khoi Nguyen, and Danil Ratnikov

@MSKCancerCenter @MSK_RadOnc @JCO_ASCO

https://t.co/neL4KQ7ZDy

[Journal of Clinical Oncology @JCO_ASCO]

Radiation Oncology at a Crossroads: Interpreting the Evidence on Proton Versus Photon Radiotherapy for Oropharyngeal Cancer. Co-authored by @sramanan03.

Read the full article. https://t.co/8gtLE4427x
#hncsm #radonc

[Sudarshan Ramanan @sramanan03]

Happy to share our new paper in Oral Oncology. We examined how socioeconomic factors influence the receipt of postoperative radiation therapy in oropharyngeal cancer.

@george_ashji, @EChrisDee, @imrtlee, N. Chadha, Y. Wu, Drs Y. Yu and A. Shamseddine

https://t.co/emKrpkgE14

[Sudarshan Ramanan @sramanan03]

@alex_allen1993 Thank you!

[Edward Christopher "Chris" Dee, MD @EChrisDee]

Incredibly proud of Sudarshan Ramanan @sramanan03, @George_Ashji, and team who led our newly published commentary in @JCO_ASCO!

A remarkable achievement and a testament to the team's leadership, intellectual curiosity, and hard work.

🔗 https://t.co/xsXfqZvGNi

[Sudarshan Ramanan @sramanan03]

Huge thank you to Yingzhi Wu!

[Sudarshan Ramanan @sramanan03]

Excited to share our latest paper in the Journal of Clinical Oncology. Grateful to my co-authors
@EChrisDee, @imrtlee, @seanmmcbride, @xrtGenomics, @george_ashji, Eric Sherman, Khoi Nguyen, and Danil Ratnikov

@MSKCancerCenter @MSK_RadOnc @JCO_ASCO

https://t.co/neL4KQ7ZDy

[NVIDIA AI @NVIDIAAI]

Love this news. More doctors around the world will be able to use OpenEvidence for free. Congrats to @OpenEvidence and @AnthropicAI 💚

[OpenEvidence @OpenEvidence]

Memorial Sloan Kettering opening its precision oncology data to physicians nationwide through OpenEvidence. Today's Forbes has the story.

@MSKCancerCenter has spent years building the world's most detailed map of which cancer mutations respond to which treatments. Until now, you had to be treated at MSK to benefit from it. Soon, an oncologist in a small practice in Montana will see the same evidence as a subspecialist in Manhattan, at the moment it matters, for the patient in front of them.

More patients getting the right treatment the first time, wherever they live. Read full article here https://t.co/ZMdrchnJ7x

[Memorial Sloan Kettering Cancer Center @MSKCancerCenter]

🚨 The @FDA has granted “Breakthrough Therapy” designation to FMISO, a specialized imaging tracer that can help identify patients with #HPV-positive #throatcancer who may safely receive less-intensive radiation treatment.

“This has been an absolute game changer for treating certain people with throat cancers caused by the human papillomavirus or HPV,” says MSK radiation oncologist @imrtlee, who pioneered the approach.

Learn more: https://t.co/Z1TGukvCcY

[JAMA @JAMA_current]

💬 Perspective by @ZekeEmanuel, MD, PhD, @AbeBakerButler, BA, @nealkhosla, MS, and @vkhosla, MS, MBA: For cognitive medical tasks, #AI alone may exceed physician-only and physician-AI hybrid care, raising policy questions about workflow, liability, regulation, reimbursement, and medical education.

https://t.co/iUwROjL0m6